Read + Share
Haas DW, Acosta EP. Implications of Efavirenz Pharmacogenetics when Switching from Efavirenz- to
Dolutegravir-containing Antiretroviral Regimens. Clin Infect Dis 2020 Jul 15. pii: 5871900. doi: 10.1093.
PMID: 32667979
|
 |
|
Haas DW, Acosta EP. Implications of Efavirenz Pharmacogenetics when Switching from Efavirenz- to
Dolutegravir-containing Antiretroviral Regimens. Clin Infect Dis 2020 Jul 15. pii: 5871900. doi: 10.1093.
PMID: 32667979
|
|
|
|